World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
76
Citations
37902
World Ranking
1791
National Ranking
820

Overview

Mark J. Rieder is affiliated with the University of Washington in the United States. Their research primarily falls within the broad field of Medicine, with a focus on several subfields including Epidemiology, Infectious Diseases, Modeling and Simulation, Radiology, Nuclear Medicine and Imaging, and Pulmonary and Respiratory Medicine.

Their work encompasses numerous topics related to infectious diseases and epidemiology, with particular emphasis on respiratory viral infections research, SARS-CoV-2 detection and testing, influenza virus research studies, SARS-CoV-2 and COVID-19 research, COVID-19 epidemiological studies, data-driven disease surveillance, and COVID-19 clinical research studies.

Mark J. Rieder has contributed to a range of recent scientific papers, demonstrating involvement in studies concerning COVID-19 and related viral infections. Notable publications include:

  • Cryptic transmission of SARS-CoV-2 in Washington State, 2020, Science
  • Evidence for Limited Early Spread of COVID-19 Within the United States, January-February 2020, 2020, MMWR Morbidity and Mortality Weekly Report
  • Early Detection of Covid-19 through a Citywide Pandemic Surveillance Platform, 2020, New England Journal of Medicine
  • Comparison of Symptoms and RNA Levels in Children and Adults With SARS-CoV-2 Infection in the Community Setting, 2021, JAMA Pediatrics
  • Cryptic transmission of SARS-CoV-2 in Washington State, 2020, bioRxiv (Cold Spring Harbor Laboratory)

The scientist frequently publishes in several venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • BMJ Open
  • Journal of Clinical Microbiology
  • BMC Infectious Diseases

Collaboration is a significant aspect of their research activities. Frequent co-authors associated with Mark J. Rieder include:

  • Helen Y. Chu
  • Deborah A. Nickerson
  • Lea M. Starita
  • Peter D. Han
  • Trevor Bedford

Mark J. Rieder's research output reflects a focus on examining the spread and detection of viral diseases, particularly SARS-CoV-2, through data-driven surveillance and clinical studies. The combination of their main and subfields showcases an interdisciplinary approach to infectious disease research and its clinical implications.

Best Publications

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations

    Brian J. O’Roak;Laura Vives;Santhosh Girirajan;Emre Karakoc

  • Selecting a Maximally Informative Set of Single-Nucleotide Polymorphisms for Association Analyses Using Linkage Disequilibrium

    Christopher S. Carlson;Michael A. Eberle;Mark J. Rieder;Qian Yi

  • Evolution and functional impact of rare coding variation from deep sequencing of human exomes

    Jacob A. Tennessen;Abigail W. Bigham;Timothy D. O'Connor;Wenqing Fu

  • Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

    Mark J. Rieder;Alexander P. Reiner;Brian F. Gage;Deborah A. Nickerson

  • Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.

    Sekar Kathiresan;Sekar Kathiresan;Olle Melander;Candace Guiducci;Aarti Surti

  • Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome

    Sarah B. Ng;Abigail W. Bigham;Kati J. Buckingham;Mark C. Hannibal;Mark C. Hannibal

  • Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations

    Brian J O'Roak;Pelagia Deriziotis;Pelagia Deriziotis;Choli Lee;Laura Vives

  • Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies.

    Seunggeun Lee;Mary J. Emond;Michael J. Bamshad;Kathleen C. Barnes

  • Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants

    Wenqing Fu;Timothy D. O’Connor;Goo Jun;Hyun Min Kang

  • Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

    BF Gage;C Eby;JA Johnson;E Deych

  • Automating the identification of DNA variations using quality-based fluorescence re-sequencing: analysis of the human mitochondrial genome.

    Mark J. Rieder;Scott L. Taylor;Vincent O. Tobe;Deborah A. Nickerson

  • Sequence variation in the human angiotensin converting enzyme.

    Mark J. Rieder;Scott L. Taylor;Andrew G. Clark;Deborah A. Nickerson

  • Using synthetic templates to design an unbiased multiplex PCR assay

    Christopher S. Carlson;Ryan O. Emerson;Anna M. Sherwood;Cindy Desmarais

  • Novel Loci for Adiponectin Levels and Their Influence on Type 2 Diabetes and Metabolic Traits: A Multi-Ethnic Meta-Analysis of 45,891 Individuals

    Z Dastani;Hivert M-F.;Hivert M-F.;N Timpson;Perry Jrb.;Perry Jrb.

  • Population History and Natural Selection Shape Patterns of Genetic Variation in 132 Genes

    Joshua M Akey;Michael A Eberle;Mark J Rieder;Christopher S Carlson

  • Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire

    Ryan O Emerson;William S DeWitt;Marissa Vignali;Jenna Gravley

  • A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

    Gregory M. Cooper;Julie A. Johnson;Taimour Y. Langaee;Hua Feng

  • Polymorphisms within the C-Reactive Protein (CRP) Promoter Region Are Associated with Plasma CRP Levels

    Christopher S. Carlson;Shelley Force Aldred;Philip K. Lee;Russell P. Tracy

  • CYP4F2 IS A VITAMIN K1 OXIDASE: AN EXPLANATION FOR ALTERED WARFARIN DOSE IN CARRIERS OF THE V433M VARIANT

    Matthew G. McDonald;Mark J. Rieder;Mariko Nakano;Clara K. Hsia

Frequent Co-Authors

Deborah A. Nickerson
Deborah A. Nickerson University of Washington
Jay Shendure
Jay Shendure University of Washington
Trevor Bedford
Trevor Bedford Fred Hutchinson Cancer Research Center
Harlan Robins
Harlan Robins Adaptive Biotechnologies (United States)
Christopher S. Carlson
Christopher S. Carlson Fred Hutchinson Cancer Research Center
Joshua D. Smith
Joshua D. Smith University of Washington
Allan E. Rettie
Allan E. Rettie University of Washington
Janet A. Englund
Janet A. Englund Seattle Children's Hospital
Helen Y. Chu
Helen Y. Chu University of Washington
Dana C. Crawford
Dana C. Crawford Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in genetics, a range of related online degrees and accelerated career pathways can help you build a strong foundation in healthcare and the sciences. Many students consider programs that balance convenience, affordability, and practical skill development.

For working nurses or those seeking to advance their roles, exploring the best online rn to bsn programs can be a strategic step. These programs often waive clinical requirements, making them more accessible for busy professionals.

Those seeking a doctorate might consider the fastest dnp online program options, designed for rapid completion without compromising educational standards. Cost is also an important factor; the cheapest dnp programs guide helps prospective students identify affordable routes to advanced nursing practice.

For a quicker entry into healthcare, the medical assistant accelerated program allows individuals to start their careers in as little as six weeks. This can be an excellent option for those eager to gain hands-on experience while working towards further education in genetics or other fields.

Best Scientists Citing Mark J. Rieder

Trending Scientists

Recently Published Articles